HIMSSCast: Should GPT-5 be HIPAA compliant, FDA regulated?
HIMSSCast: Should GPT-5 be HIPAA compliant, FDA regulated? | MobiHealthNews
Skip to main content…
Continue ReadingHIMSSCast: Should GPT-5 be HIPAA compliant, FDA regulated? | MobiHealthNews
Skip to main content…
Continue Reading‘DT-GPT’: digital twin LLM in Melbourne beats MLs in predictive accuracy | MobiHealthNews
Skip to main content…
Continue ReadingNicole Ventrone, Partner at Beghou
Pharma is embracing GPT-5, shifting AI from chatbot to enterprise agent as it accelerates productivity amid regulatory challenges.
Large pharmaceutical and biotech companies have spent the last couple of years running…
Continue ReadingElectronic Health Records (EHRs) contain vast clinical data that are difficult for providers to synthesize. Generative AI with Large Language Models (LLMs) can summarize records to reduce cognitive burden, but ensuring accuracy requires reliable…
Continue ReadingWe evaluated the ability of three leading LLMs (GPT-4o, Gemini 2.0 Experimental, and Claude 3.5 Sonnet) to recognize human facial expression using the NimStim dataset. GPT and Gemini matched or exceeded human performance, especially…
Continue ReadingMultimodal smartphone sensor data provide rich insights into real-world behavioural patterns associated with anxiety and depression symptoms. We propose that variability in daily routines across life aspects may act as a personalised digital marker,…
Continue ReadingGenerative artificial intelligence is revolutionizing digital twin development, enabling virtual patient representations that predict health trajectories, with large language models (LLMs) showcasing untapped clinical forecasting potential. We developed the Digital Twin—Generative Pretrained Transformer (DT-GPT),…
Continue ReadingNews
OpenAI says that its newly released GPT-5 is its best model yet for answering health questions as an “active thought partner,” offering improved explanations of test results and health risks, better understanding of medical…
Continue ReadingClinical evidence synthesis largely relies on systematic reviews (SR) of clinical studies from medical literature. Here, we propose a generative artificial intelligence (AI) pipeline named TrialMind to streamline study search, study screening, and data…
Continue ReadingStroke is a leading cause of global morbidity and mortality, disproportionately impacting lower socioeconomic groups. In this study, we evaluated three generative LLMs—GPT, Claude, and Gemini—across four stages of stroke care: prevention, diagnosis, treatment,…
Continue Reading